Cytosorbents Corp (CTSO)
Cytosorbents Corp (CTSO)
| Balance Sheets | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 |
|---|---|---|---|---|
| Cash and cash equivalents | 4,813 | 6,249 | 7,536 | 10,204 |
| Accounts receivable, net of allowances of 164 as of march 31, 2026 and december 31, 2025 | 7,152 | 7,550 | 7,427 | 7,743 |
| Inventories - net | 4,481 | 5,281 | 4,002 | 3,710 |
| Prepaid expenses and other current assets | 1,311 | 1,554 | 2,348 | 1,330 |
| Total current assets | 17,757 | 20,634 | 21,313 | 22,987 |
| Property and equipment, gross | NaN | NaN | 13,482 | NaN |
| Less accumulated depreciation and amortization | NaN | NaN | 5,289 | NaN |
| Property and equipment - net | 7,510 | 7,823 | 8,193 | 8,466 |
| Restricted cash | 1,522 | 1,522 | 1,522 | 1,522 |
| Right-of-use asset | 10,769 | 10,924 | 11,075 | 11,223 |
| Patents - net | 2,952 | 3,226 | NaN | NaN |
| Other assets | 52 | 53 | 3,647 | 3,792 |
| Total assets | 40,562 | 44,182 | 45,750 | 47,990 |
| Accounts payable | 3,132 | 2,869 | 3,035 | 3,394 |
| Accrued expenses and other current liabilities | 5,960 | 6,299 | 6,559 | 5,953 |
| Lease liability - current portion | 565 | 541 | 518 | 495 |
| Current maturities of long-term debt, net of debt discount | 6,646 | NaN | NaN | NaN |
| Total current liabilities | 16,303 | 9,709 | 10,112 | 9,842 |
| Lease liability, net of current portion | 11,752 | 11,903 | 12,051 | 12,185 |
| Long-term debt, net of current portion and debt discount | 10,313 | 16,667 | 14,567 | 14,377 |
| Total liabilities | 38,368 | 38,279 | 36,730 | 36,404 |
| Common stock, par value 0.001, 100,000,000 shares authorized as of march 31, 2026 and december 31, 2025 62,733,305 and 62,804,305 shares issued and outstanding as of march 31, 2026 and december 31, 2025 respectively | 63 | 63 | 63 | 63 |
| Additional paid-in capital | 321,568 | 321,024 | 319,511 | 319,023 |
| Accumulated other comprehensive loss | -2,101 | -2,977 | -3,844 | -3,960 |
| Accumulated deficit | -317,336 | -312,207 | -306,710 | -303,540 |
| Total stockholders' equity | 2,194 | 5,903 | 9,020 | 11,586 |
| Total liabilities and stockholders' equity | 40,562 | 44,182 | 45,750 | 47,990 |